287 related articles for article (PubMed ID: 31844417)
21. miR-338-3p Plays a Significant Role in Casticin-Induced Suppression of Acute Myeloid Leukemia via Targeting PI3K/Akt Pathway.
Yu K; Wang J; Hou J; Zhang L; Liang H
Biomed Res Int; 2022; 2022():9214130. PubMed ID: 35765408
[TBL] [Abstract][Full Text] [Related]
22. miR-148a-3p suppresses the progression of acute myeloid leukemia via targeting cyclin-dependent kinase 6 (CDK6).
Zhou H; Jia X; Yang F; Shi P
Bioengineered; 2021 Dec; 12(1):4508-4519. PubMed ID: 34308752
[TBL] [Abstract][Full Text] [Related]
23. Simvastatin regulates the proliferation, apoptosis, migration and invasion of human acute myeloid leukemia cells via miR-19a-3p/HIF-1α axis.
Tian H; Qiang T; Wang J; Ji L; Li B
Bioengineered; 2021 Dec; 12(2):11898-11908. PubMed ID: 34895042
[TBL] [Abstract][Full Text] [Related]
24. LncRNA KCNQ1OT1 contributes to the progression and chemoresistance in acute myeloid leukemia by modulating Tspan3 through suppressing miR-193a-3p.
Sun H; Sun Y; Chen Q; Xu Z
Life Sci; 2020 Jan; 241():117161. PubMed ID: 31837329
[TBL] [Abstract][Full Text] [Related]
25. Hsa_circ_0002483 regulates miR-758-3p/MYC axis to promote acute myeloid leukemia progression.
Xiao Y; Ming X; Wu J
Hematol Oncol; 2021 Apr; 39(2):243-253. PubMed ID: 33283885
[TBL] [Abstract][Full Text] [Related]
26. Matrine regulates miR-495-3p/miR-543/PDK1 axis to repress the progression of acute myeloid leukemia via the Wnt/β-catenin pathway.
Lei Y; Li X; Zhu L
Chem Biol Drug Des; 2024 Jan; 103(1):e14441. PubMed ID: 38230785
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis.
Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J
Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of MicroRNA-149-5p Induces Apoptosis of Acute Myeloid Leukemia Cell Line THP-1 by Targeting Fas Ligand (FASLG).
Tian P; Yan L
Med Sci Monit; 2016 Dec; 22():5116-5123. PubMed ID: 28013316
[TBL] [Abstract][Full Text] [Related]
29. [miR-148b-3p inhibits the proliferation and autophagy of acute myeloid leukemia cells by targeting ATG14].
Jiang X; Jing Y; Lei L; Peng M; Xiao Q; Ren J; Tao Y; Huang J; Zhang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Oct; 37(10):881-890. PubMed ID: 34670664
[TBL] [Abstract][Full Text] [Related]
30. miR-342-3p Inhibits Acute Myeloid Leukemia Progression by Targeting SOX12.
Wang Y; Guo X; Wang L; Xing L; Zhang X; Ren J
Oxid Med Cell Longev; 2022; 2022():1275141. PubMed ID: 36120594
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia.
Wang XS; Gong JN; Yu J; Wang F; Zhang XH; Yin XL; Tan ZQ; Luo ZM; Yang GH; Shen C; Zhang JW
Blood; 2012 May; 119(21):4992-5004. PubMed ID: 22493297
[TBL] [Abstract][Full Text] [Related]
32. MiR-199a-3p Overexpression Suppressed Cell Proliferation and Sensitized Chronic Myeloid Leukaemia Cells to Imatinib by Inhibiting mTOR Signalling.
Liu X; Cui MM; Zhu HZ; Fu PY; Wang GC; Huang L
Acta Haematol; 2022; 145(5):484-498. PubMed ID: 35313299
[TBL] [Abstract][Full Text] [Related]
33. Silencing of long noncoding RNA TUG1 inhibits viability and promotes apoptosis of acute myeloid leukemia cells by targeting microRNA-221-3p/KIT axis.
Zhang X; Yang L; Xu G
Clin Hemorheol Microcirc; 2020; 76(3):425-437. PubMed ID: 32804119
[TBL] [Abstract][Full Text] [Related]
34. MiR-204 suppresses the progression of acute myeloid leukemia through HGF/c-Met pathway.
Nie D; Ma P; Chen Y; Zhao H; Liu L; Xin D; Cao W; Wang F; Meng X; Liu L; Xie M; Sun L
Hematology; 2021 Dec; 26(1):931-939. PubMed ID: 34789086
[TBL] [Abstract][Full Text] [Related]
35. Depletion of Ars2 inhibits cell proliferation and leukemogenesis in acute myeloid leukemia by modulating the miR-6734-3p/p27 axis.
Hu X; Xu S; Chen Y; Gao Z; Li Y; Hu J; Huang X; Zhang Y; Jiang X; Li L; Yang C; Chen J; Gao N
Leukemia; 2019 May; 33(5):1090-1101. PubMed ID: 30518811
[TBL] [Abstract][Full Text] [Related]
36. The hsa-miR-214-3p/ATGL axis regulates aberrant lipolysis to promote acute myeloid leukemia progression via PPARα in vitro.
Li Y; Yuan S; Wu W; Zhou J; Zhang P; Li D; Zhang Y; Lou S
Biochem Biophys Res Commun; 2022 Jun; 608():73-81. PubMed ID: 35395550
[TBL] [Abstract][Full Text] [Related]
37. microRNA-125a-3p reduces cell proliferation and migration by targeting Fyn.
Ninio-Many L; Grossman H; Shomron N; Chuderland D; Shalgi R
J Cell Sci; 2013 Jul; 126(Pt 13):2867-76. PubMed ID: 23606749
[TBL] [Abstract][Full Text] [Related]
38. The malignancy suppression role of miR-23a by targeting the BCR/ABL oncogene in chromic myeloid leukemia.
Xishan Z; Xianjun L; Ziying L; Guangxin C; Gang L
Cancer Gene Ther; 2014 Sep; 21(9):397-404. PubMed ID: 25213664
[TBL] [Abstract][Full Text] [Related]
39. TUG1 weakens the sensitivity of acute myeloid leukemia cells to cytarabine by regulating miR-655-3p/CCND1 axis.
Zhang B; Sun YF; Zhang XM; Jiang N; Chen Q
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4940-4953. PubMed ID: 32432757
[TBL] [Abstract][Full Text] [Related]
40. CircPTK2 promotes cell viability, cell cycle process, and glycolysis and inhibits cell apoptosis in acute myeloid leukemia by regulating miR-582-3p/ALG3 axis.
Shang Z; Ming X; Wu J; Liu W; Xiao Y
Expert Rev Hematol; 2022 Dec; 15(12):1073-1083. PubMed ID: 35980117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]